Ranks distinct AI gain and problem claims from the published record. Scores reward impact, independent source strength, scale, confidence, and recency.
In a peer-reviewed study published October 27, 2024, researchers interviewed nineteen individuals about using generative AI chatbots like ChatGPT for mental health. Participants described high engagement and meaningful support, organized into themes of emotional sanctuary, insightful guidance about relationships, joy of connection, and comparisons to human therapy.
As of its March 5 2026 publication, this narrative literature review surveyed how neural network architectures are used for real-time financial fraud detection, covering MLPs, LSTMs, CNNs, Autoencoders, GNNs and Transformers, and the production requirement to operate within sub-100-millisecond payment authorization pipelines, with examples from credit card networks and Brazil's PIX system.
In a retrospective study published July 11 2026, investigators tested 500 chest radiographs from one tertiary center with two AI systems, M4CXR and ChatGPT-4o, having four radiologists score AI-generated reports for finding detection and RADPEER discrepancies. M4CXR reached 55.8% complete concordance versus 19.8% for GPT-4o and reduced mean reporting time to 16.3 seconds from 179.2 seconds unaided.
By late 2024, a review of 237 publications from 2010 to 2024 found AI and ML increasingly studied as tools for energy efficiency and climate mitigation, with over 60% of papers appearing in the last two years and focus areas including sustainable construction and climate forecasting.
Researchers validated a previously developed AI system that detects self-harm in emergency department triage notes using extensive text normalisation and 1931 features. They tested it prospectively on 329,655 notes from the original major metropolitan hospital in Melbourne and externally on 316,877 notes from a regional hospital 150 km away covering 2012-2021.
Early gastric cancer (EGC) is increasingly managed by endoscopic resection (ER); however, lymph node metastasis (LNM), which occurs in approximately 5%-10% of cases, remains the key determinant for recommending additional gastrectomy. Current guideline-based strategies, including the eCura system, provide structured risk stratification but rely on categorical decision-making and may lead to overtreatment, as nearly 90% of patients undergoing additional surgery do not have LNM.